ALS Precision Therapy Startup Wins Golden Ticket

News   Dec 20, 2017 | Original Story from Amgen

 
Innovative ALS Therapy Startup Wins Golden Ticket Funding From Amgen
 
 
 

RELATED ARTICLES

Lunaphore and Vitro Sign Collaboration Agreement

News

Companies announce a collaboration agreement to develop In Situ Hybridization (ISH) protocols for RNA and DNA targets in tissue using reagents provided by Vitro on Lunaphore’s rapid autostaining platform.

READ MORE

Worldwide Clinical Trials Receives 2018 CRO Leadership Awards

News

Life Science Leader and Industry Standard Research assess 70 contract research organizations, honoring Worldwide Clinical Trials for fifth consecutive year.

READ MORE

Tuberculosis: Pharmacists Develop Substance to Counteract Antimicrobial Resistance

News

Antimicrobial resistance is on the rise worldwide. This is becoming a problem for infectious diseases like tuberculosis as there are only a few active substances available to combat such diseases. Pharmacists have now found a way to increase the efficacy of a common tuberculosis agent while, at the same time, reducing resistance to it.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery Neuroscience Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE